Literature DB >> 4342029

The action of bombesin on the systemic arterial blood pressure of some experimental animals.

V Erspamer, P Melchiorri, N Sopranzi.   

Abstract

1. The changes in blood pressure in response to parenteral administration of bombesin, the active tetradecapeptide of the skin of the European discoglossid frogs Bombina bombina and Bombina variegata variegata have been investigated in some experimental animals.2. In most species, the polypeptide elicited hypertension which was usually gradual in onset and slow to disappear. Blood pressure increases rarely exceeded 40-50 mmHg. At the beginning of an experiment some dose-response relationship could often be observed, but later tachyphylaxis developed. During an intravenous infusion of bombesin the rise in blood pressure could sometimes be maintained at a steady level as long as the infusion was continued, but at other times, the rise of pressure slowly subsided with continued administration of the polypeptide. In the rat and the chicken hypertension elicited by high doses of bombesin was often followed by secondary hypotension.3. Bombesin-induced hypertension was apparently not affected by pretreatment with either alpha- or beta-adrenergic blocking agents. Similarly secondary hypotension was not abolished by atropine. Thus, the effect of bombesin on vascular smooth muscle seems to be predominantly a direct one.4. Angiotensin was usually more potent than bombesin, and its effect on blood pressure was more rapid and of shorter duration. Tachyphylaxis to angiotensin was lacking or moderate.5. In sharp contrast to the other species, the monkey responded to bombesin with frank hypotension, which was usually proportional to the dose. In the monkey the hypotensive effect of bombesin was equal to, or greater than that of eledoisin or physalaemin and bombesin-induced hypotension was of longer duration than that of the other polypeptides. Tachyphylaxis was moderate for low and adequately spaced doses of the polypeptide, but prompt and intense for high doses. Long-lasting hypotension was obtained by intravenous infusion of bombesin, but repeated infusions caused tachyphylaxis. Bombesin-induced hypotension was not affected by pretreatment with atropine.6. Bombesin may be easily distinguished from all other known peptides active on vascular and extravascular smooth muscle by its effects on blood pressure. This does not apply to bombesin-like peptides, such as alytesin and ranatensin.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4342029      PMCID: PMC1666167          DOI: 10.1111/j.1476-5381.1972.tb08100.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  The relationship between the vascular responses to the peptides ranatensin and angiotensin.

Authors:  W J Louis; T Tanimura; J J Pisano
Journal:  Eur J Pharmacol       Date:  1971-05       Impact factor: 4.432

2.  On the action of bombesin on the kidney of the rat and the dog.

Authors:  P Melchiorri; N Sopranzi; V Erspamer
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

Review 3.  Biogenic amines and active polypeptides of the amphibian skin.

Authors:  V Erspamer
Journal:  Annu Rev Pharmacol       Date:  1971       Impact factor: 13.820

4.  The action of ranatensin, a new polypeptide from amphibian skin, on the blood pressure of experimental animals.

Authors:  R G Geller; W C Govier; J J Pisano; T Tanimura; B Van Clineschmidt
Journal:  Br J Pharmacol       Date:  1970-12       Impact factor: 8.739

5.  Occurrence of bombesin and alytesin in extracts of the skin of three European discoglossid frogs and pharmacological actions of bombesin on extravascular smooth muscle.

Authors:  V Erspamer; G F Erspamer; M Inselvini; L Negri
Journal:  Br J Pharmacol       Date:  1972-06       Impact factor: 8.739

  5 in total
  8 in total

1.  Relative potency of bombesin-like peptides.

Authors:  M Broccardo; G Falconieri Erspamer; P Melchiorri; L Negri; R de Castiglione
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  The actions of bombesin on gastric secretion of the dog and the rat.

Authors:  G Bertaccini; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

3.  Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats.

Authors:  P J Janssen; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Impact of vasoactive intestinal polypeptide and gastrin-releasing peptide on small bowel microcirculation and mucosal injury after hepatic ischemia/reperfusion in rats.

Authors:  Ingo Leister; J Sydow; T Stojanovic; L Füzesi; B Sattler; M Heuser; H Becker; P M Markus
Journal:  Int J Colorectal Dis       Date:  2004-07-27       Impact factor: 2.571

5.  Parallel bioassay of bombesin and litorin, a bombesin-like peptide from the skin of Litoria aurea.

Authors:  R Endean; V Erspamer; G Falconieri Erspamer; G Improta; P Melchiorri; L Negri; N Sopranzi
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

6.  BR-bombesin: a novel bombesin-related peptide from the skin secretion of the Chaco tree frog (Boana raniceps) with physiological gastric effects.

Authors:  Nayara Alves de Sousa; Mariela M Marani; André Luís Fernandes Lopes; Emanuelle Morais Silva; Eder Alves Barbosa; Andreanne Gomes Vasconcelos; Felipe T B Kuzniewski; Suellen Sousa Lustosa; Karina Pereira Gomes; Diego Basile Colugnati; Jefferson A Rocha; Lucianna Helene Santos; Marcelo P Benquerer; Patrick Quelemes; Leiz Véras; Daniel C Moreira; Kalinne Kelly Lima Gadelha; Pedro Jorge Caldas Magalhães; Alexandra Plácido; Peter Eaton; Lucas Nicolau; Jand Venes R Medeiros; José R S A Leite
Journal:  Amino Acids       Date:  2022-03-13       Impact factor: 3.520

7.  Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin.

Authors:  D M Burns; B Walker; J Gray; J Nelson
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

8.  Blockade of Rostral Ventrolateral Medulla (RVLM) Bombesin Receptor Type 1 Decreases Blood Pressure and Sympathetic Activity in Anesthetized Spontaneously Hypertensive Rats.

Authors:  Izabella S Pinto; Aline A Mourão; Elaine F da Silva; Amanda S Camargo; Stefanne M Marques; Karina P Gomes; James O Fajemiroye; Angela A da Silva Reis; Ana C S Rebelo; Marcos L Ferreira-Neto; Daniel A Rosa; André H Freiria-Oliveira; Carlos H Castro; Eduardo Colombari; Diego B Colugnati; Gustavo R Pedrino
Journal:  Front Physiol       Date:  2016-06-02       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.